Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (000766.SZ)

CNY 16.85

(0.36%)

Revenue Summary of Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

  • Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's latest annual revenue in 2023 was 1.46 Billion CNY , down -0.55% from previous year.
  • Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's latest quarterly revenue in 2024 Q3 was 319.4 Million CNY , down -9.06% from previous quarter.
  • Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd reported a annual revenue of 1.47 Billion CNY in annual revenue 2022, down -2.95% from previous year.
  • Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd reported a annual revenue of 1.51 Billion CNY in annual revenue 2021, up 36.31% from previous year.
  • Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd reported a quarterly revenue of 319.4 Million CNY for 2024 Q3, down -9.06% from previous quarter.
  • Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd reported a quarterly revenue of 295.57 Million CNY for 2024 Q1, down -30.58% from previous quarter.

Annual Revenue Chart of Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (2023 - 1994)

Historical Annual Revenue of Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (2023 - 1994)

Year Revenue Revenue Growth
2023 1.46 Billion CNY -0.55%
2022 1.47 Billion CNY -2.95%
2021 1.51 Billion CNY 36.31%
2020 1.11 Billion CNY -43.77%
2019 1.97 Billion CNY -5.6%
2018 2.09 Billion CNY 37.67%
2017 1.52 Billion CNY 78.97%
2016 850.08 Million CNY 330.29%
2015 197.55 Million CNY -5.21%
2014 208.41 Million CNY 41.03%
2013 147.78 Million CNY 15.77%
2012 127.64 Million CNY -29.66%
2011 181.47 Million CNY 7.01%
2010 169.58 Million CNY 0.85%
2009 168.16 Million CNY 5.2%
2008 159.85 Million CNY 5.45%
2007 151.58 Million CNY 7.25%
2006 141.33 Million CNY 0.13%
2005 141.15 Million CNY 41.33%
2004 99.87 Million CNY -27.05%
2003 136.89 Million CNY -14.97%
2002 160.99 Million CNY 60.3%
2001 100.43 Million CNY -80.08%
2000 504.18 Million CNY 76.96%
1999 284.9 Million CNY 5.14%
1998 270.98 Million CNY 12.41%
1997 241.07 Million CNY 47.11%
1996 163.86 Million CNY 23.68%
1995 132.48 Million CNY 33.24%
1994 99.43 Million CNY 0.0%

Peer Revenue Comparison of Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

Name Revenue Revenue Difference
Shenzhen Neptunus Bioengineering Co., Ltd. 36.41 Billion CNY 95.984%
Anhui Fengyuan Pharmaceutical Co., Ltd. 4.27 Billion CNY 65.789%
Dong-E-E-Jiao Co.,Ltd. 4.71 Billion CNY 68.98%
Livzon Pharmaceutical Group Inc. 12.27 Billion CNY 88.088%
Hainan Haiyao Co., Ltd. 1.45 Billion CNY -0.374%
Tus-Pharmaceutical Group Co., Ltd. 395.92 Million CNY -269.433%
Jilin Aodong Pharmaceutical Group Co., Ltd. 3.44 Billion CNY 57.593%
Changchun High-Tech Industries (Group) Inc. 14.46 Billion CNY 89.885%
Apeloa Pharmaceutical Co.,Ltd 11.47 Billion CNY 87.252%
PKU HealthCare Corp.,Ltd. 2.19 Billion CNY 33.327%
Chengdu Huasun Technology Group Inc., Ltd. 1 Billion CNY -45.775%
Dezhan Healthcare Company Limited 498.08 Million CNY -193.657%
Jinling Pharmaceutical Company Limited 2.78 Billion CNY 47.494%
Jiuzhitang Co., Ltd. 2.91 Billion CNY 49.897%
Huapont Life Sciences Co., Ltd. 11.59 Billion CNY 87.385%
Zhejiang Jingxin Pharmaceutical Co., Ltd. 3.95 Billion CNY 62.99%
Shandong Wohua Pharmaceutical Co., Ltd. 894.31 Million CNY -63.552%
Hengkang Medical Group Co., Ltd. 3.59 Billion CNY 59.263%
Guangdong Zhongsheng Pharmaceutical Co., Ltd. 2.61 Billion CNY 43.971%
Qianjiang Yongan Pharmaceutical Co., Ltd. 962.8 Million CNY -51.918%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 5.42 Billion CNY 73.022%
Jinhe Biotechnology CO., LTD. 2.17 Billion CNY 32.724%
Teyi Pharmaceutical Group Co.,Ltd 1.06 Billion CNY -37.055%
Kunming Longjin Pharmaceutical Co., Ltd. 86.62 Million CNY -1588.559%
Beijing Aosaikang Pharmaceutical Co., Ltd. 1.44 Billion CNY -1.331%
Chengdu Kanghong Pharmaceutical Group Co., Ltd 3.95 Billion CNY 63.04%
Anhui Huangshan Capsule Co., Ltd. 458.36 Million CNY -219.103%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd 980.82 Million CNY -49.126%
Zhuhai Rundu Pharmaceutical Co., Ltd. 1.29 Billion CNY -13.22%
Huaren Pharmaceutical Co., Ltd. 1.63 Billion CNY 10.609%
Tianjin Ringpu Bio-Technology Co.,Ltd. 2.24 Billion CNY 34.962%
Shanxi Zhendong Pharmaceutical Co.,Ltd 3.62 Billion CNY 59.662%
Fuan Pharmaceutical (Group) Co., Ltd. 2.64 Billion CNY 44.758%
Hybio Pharmaceutical Co., Ltd. 431.38 Million CNY -239.065%
Baotou Dongbao Bio-Tech Co.,Ltd 974.51 Million CNY -50.093%
Hunan Er-Kang Pharmaceutical Co., Ltd 1.76 Billion CNY 17.326%
Changjiang Pharmaceutical Group Co., Ltd. 1.19 Billion CNY -22.137%
Zhejiang Garden Bio-chemical High-tech Co., Ltd. 1.09 Billion CNY -33.62%
Fujian Cosunter Pharmaceutical Co., Ltd. 422.71 Million CNY -246.019%
Beijing Science Sun Pharmaceutical Co., Ltd. 476.56 Million CNY -206.917%
Zhejiang Xinguang Pharmaceutical Co., Ltd. 270.39 Million CNY -440.929%
Hainan Poly Pharm. Co., Ltd 1.3 Billion CNY -12.127%
Jiangxi Synergy Pharmaceutical Co., Ltd. 722.13 Million CNY -102.547%
Wuhan Hiteck Biological Pharma Co.,Ltd 602.28 Million CNY -142.854%
Shandong Xinhua Pharmaceutical Company Limited 8 Billion CNY 81.736%
Zhejiang Tianyu Pharmaceutical Co., Ltd. 2.52 Billion CNY 42.124%
PharmaBlock Sciences (Nanjing), Inc. 1.72 Billion CNY 15.217%
Jinghua Pharmaceutical Group Co., Ltd. 1.49 Billion CNY 1.864%
Zhejiang Hisoar Pharmaceutical Co., Ltd. 2.17 Billion CNY 32.654%
Betta Pharmaceuticals Co., Ltd. 2.45 Billion CNY 40.45%
Tibet AIM Pharm. Inc. 667.03 Million CNY -119.278%
Shenzhen Kangtai Biological Products Co., Ltd. 3.47 Billion CNY 57.938%
Shandong Shanda Wit Science and Technology Co., Ltd. 2.48 Billion CNY 41.12%
Pacific Shuanglin Bio-pharmacy Co., LTD 2.32 Billion CNY 37.19%
Zhejiang AngLiKang Pharmaceutical CO.,LTD. 1.62 Billion CNY 10.037%
Xiamen Kingdomway Group Company 3.1 Billion CNY 52.856%
ShanXi C&Y Pharmaceutical Group Co., Ltd. 799.3 Million CNY -82.993%
Walvax Biotechnology Co., Ltd. 4.11 Billion CNY 64.445%
Sunflower Pharmaceutical Group Co.,Ltd 5.63 Billion CNY 74.028%
Harbin Gloria Pharmaceuticals Co., Ltd 2.58 Billion CNY 43.524%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. 24.73 Billion CNY 94.088%
Hunan Hansen Pharmaceutical Co., Ltd. 955.53 Million CNY -53.074%
Changzhou Qianhong Biopharma CO.,LTD 1.79 Billion CNY 18.463%
Shenzhen Weiguang Biological Products Co., Ltd. 1.04 Billion CNY -39.501%
Honz Pharmaceutical Co., Ltd. 739.56 Million CNY -97.773%
Northeast Pharmaceutical Group Co., Ltd. 8.16 Billion CNY 82.078%
Guizhou Xinbang Pharmaceutical Co., Ltd. 6.46 Billion CNY 77.361%
Tianjin Lisheng Pharmaceutical Co.,Ltd. 1.13 Billion CNY -29.421%
Zhejiang Yatai Pharmaceutical Co., Ltd. 420.64 Million CNY -247.722%
Zhejiang NHU Company Ltd. 15.11 Billion CNY 90.324%
ApicHope Pharmaceutical Co., Ltd 2.5 Billion CNY 41.574%
Shanghai Kaibao Pharmaceutical CO.,Ltd 1.59 Billion CNY 8.242%
Beijing SL Pharmaceutical Co., Ltd. 1.01 Billion CNY -43.63%
Yunnan Baiyao Group Co.,Ltd 38.9 Billion CNY 96.24%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD 1.08 Billion CNY -35.426%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. 839.25 Million CNY -74.281%
Guangdong Lifestrong Pharmacy Co., Ltd. 292.39 Million CNY -400.235%
Huadong Medicine Co., Ltd 40.39 Billion CNY 96.379%
Jiangsu Nhwa Pharmaceutical Co., LTD 4.97 Billion CNY 70.591%
Harbin Medisan Pharmaceutical Co., Ltd. 1.18 Billion CNY -23.247%
LanZhou Foci Pharmaceutical Co.,Ltd. 1.16 Billion CNY -25.753%
Tianjin Chase Sun Pharmaceutical Co.,Ltd 6.12 Billion CNY 76.128%
Beijing Beilu Pharmaceutical Co., Ltd 890.71 Million CNY -64.213%
Nanjing Hicin Pharmaceutical Co., Ltd. 517.83 Million CNY -182.461%
Renhe Pharmacy Co., Ltd. 5.03 Billion CNY 70.933%
Chongqing Pharscin Pharmaceutical Co., Ltd. 691.54 Million CNY -111.509%
Zhejiang Xianju Pharmaceutical Co.,Ltd. 4.12 Billion CNY 64.528%
Luoxin Pharmaceuticals Group Stock Co., Ltd. 2.34 Billion CNY 37.563%
Guizhou Bailing Group Pharmaceutical Co., Ltd. 4.26 Billion CNY 65.689%